nervous system
• amyloid beta deposits in the hippocampus, in the subiculum and thalamus
(J:132221)
• deposits are observed by 52 weeks of age
(J:143551)
|
• 65% loss of NPY interneurons in the hippocampus
|
• thinning of the CA3 and subiculum, with a 40% loss of neurons in the CA3 region
(J:132221)
• neuronal loss
(J:143551)
|
• 35% loss of neurons in the subiculum
(J:132221)
• neuronal loss
(J:143551)
|
• mice show intraneuronal aggregrates of tau
• hyperphosphorylated tau is seen in the brain and in neuronal processes associated with blood vessels
|
• neuronal loss is observed in hippocampus, subiculum and CA3
|
• 30% loss of NeuN-immunopositive neurons in the hippocampus, 35% loss in the subiculum, and 40% loss in the CA3 region of the hippocampus
• loss of neuropeptide Y-immunopositive neurons particularly in the CA3 region and in the subiculum
|
• 30% loss of neurons in the hippocampus
• 50% reduction in neuropeptide Y-immunopositive neurons overall throughout the hippocampus, a 65% reduction in the CA3 region, and 50% reduction in the subiculum
|
homeostasis/metabolism
• amyloid beta deposits in the hippocampus, in the subiculum and thalamus
(J:132221)
• deposits are observed by 52 weeks of age
(J:143551)
|
behavior/neurological
• mice make more errors in the radial-arm water maze than single Tg(Thy1-APPSwDutIowa)BWevn transgenics, especially on subsequent days, indicating slowed learning and/or retrieval of the task
• mice show increased impaired performance on the Barnes maze compared to single Tg(Thy1-APPSwDutIowa)BWevn transgenics
|
cellular
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Alzheimer's disease | DOID:10652 | J:132221 |